Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

The Role of Non-Coding RNAs in Myelodysplastic Neoplasms

Version 1 : Received: 28 August 2023 / Approved: 28 August 2023 / Online: 29 August 2023 (13:42:14 CEST)

A peer-reviewed article of this Preprint also exists.

Georgoulis, V.; Koumpis, E.; Hatzimichael, E. The Role of Non-Coding RNAs in Myelodysplastic Neoplasms. Cancers 2023, 15, 4810. Georgoulis, V.; Koumpis, E.; Hatzimichael, E. The Role of Non-Coding RNAs in Myelodysplastic Neoplasms. Cancers 2023, 15, 4810.

Abstract

Myelodysplastic syndromes or neoplasms (MDS) are a heterogeneous group of myeloid clonal disorders characterized by peripheral blood cytopenias, blood and marrow cell dysplasia and an increased risk for evolution to acute myeloid leukemia (AML). Non-coding RNAs, especially microRNAs and long non-coding RNAs serve as regulators of normal and malignant hematopoiesis and have been implicated in carcinogenesis. This review will present a comprehensive summary of the biology and role of non-coding RNAs, including the less studied circRNA, siRNA, piRNA, and snoRNA as potential prognostic and/or predictive biomarkers or therapeutic targets in MDS.

Keywords

myelodysplastic syndromes; non-coding RNA; microRNA; lnc-RNA; circ-RNA; piwi-RNA; t-RNA; sno-RNA

Subject

Medicine and Pharmacology, Hematology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.